COVID-19疫苗不良事件信号检测中的掩蔽效应
该研究基于疫苗不良事件报告系统数据,采用三种常用统计信号检测方法和一种基于回归的进阶方法,分析COVID-19疫苗相关不良事件信号的时间演变。结果表明,常用方法可能因掩蔽效应导致信号未被检出或延迟,进阶方法可部分缓解该问题,掩蔽在COVID-19疫苗信号检测中更易发生且动态变化。
要点
- 常用信号检测方法在COVID-19疫苗监测中可能因掩蔽效应漏检或延迟信号。
- 掩蔽效应在COVID-19疫苗信号检测中比一般情况更常见。
- 进阶回归方法可部分缓解掩蔽问题,但需谨慎评估。
核心结论
- 掩蔽效应是COVID-19疫苗安全监测中可处理但需重视的问题,尤其在紧急使用授权产品中。
研究设计与样本
- 基于疫苗不良事件报告系统数据,比较三种常用统计信号检测方法与一种进阶回归方法。
主要发现
- 常用方法可能因掩蔽导致COVID-19疫苗相关不良事件信号未检出或延迟。
- 掩蔽效应相对于所有可能的统计关联虽罕见,但在COVID-19疫苗信号检测中更易发生。
- 掩蔽的程度、方向、影响和根源随数据性质变化而动态改变。
- 进阶方法可部分缓解掩蔽问题。
临床怎么用
- 在COVID-19疫苗安全监测中应考虑掩蔽效应,并评估进阶信号检测方法的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Statistical signal detection is a crucial tool for rapidly identifying potential risks associated with pharmaceutical products. The unprecedented environment created by the coronavirus disease 2019 (COVID-19) pandemic for vaccine surveillance predisposes commonly applied signal detection methodologies to a statistical issue called the masking effect, in which signals for a vaccine of interest are hidden by the presence of other reported vaccines. This masking effect may in turn limit or delay our understanding of the risks associated with new and established vaccines. OBJECTIVE: The aim is to investigate the problem of masking in the context of COVID-19 vaccine signal detection, assessing its impact, extent, and root causes. METHODS: Based on data underlying the Vaccine Adverse Event Reporting System, three commonly applied statistical signal detection methodologies, and a more advanced regression-based methodology, we investigate the temporal evolution of signals corresponding to five largely recognized adverse events and two potentially new adverse events. RESULTS: The results demonstrate that signals of adverse events related to COVID-19 vaccines may be undetected or delayed due to masking when generated by methodologies currently utilized by pharmacovigilance organizations, and that a class of advanced methodologies can partially alleviate the problem. The results indicate that while masking is rare relative to all possible statistical associations, it is much more likely to occur in COVID-19 vaccine signaling, and that its extent, direction, impact, and roots are not static, but rather changing in accordance with the changing nature of data. CONCLUSIONS: Masking is an addressable problem that merits careful consideration, especially in situations such as COVID-19 vaccine safety surveillance and other emergency use authorization products.
引用
- Harpaz R, DuMouchel W, Van Manen R, et al. Signaling COVID-19 Vaccine Adverse Events. Drug Saf. 2022. PMID: 35737293. doi:10.1007/s40264-022-01186-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。